231 related articles for article (PubMed ID: 24867464)
41. In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2005; 22(2):129-38. PubMed ID: 15965275
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
J Obstet Gynaecol Res; 2006 Apr; 32(2):148-54. PubMed ID: 16594917
[TBL] [Abstract][Full Text] [Related]
43. Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect.
Maupas-Schwalm F; Bedel A; Augé N; Grazide MH; Mucher E; Thiers JC; Salvayre R; Nègre-Salvayre A
Cell Signal; 2009 Dec; 21(12):1925-34. PubMed ID: 19735728
[TBL] [Abstract][Full Text] [Related]
44. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
[TBL] [Abstract][Full Text] [Related]
45. Protein kinase C-mediated regulation of matrix metalloproteinase and tissue inhibitor of metalloproteinase production in a human retinal müller cells.
Miyata Y; Kase M; Sugita Y; Shimada A; Nagase T; Katsura Y; Kosano H
Curr Eye Res; 2012 Sep; 37(9):842-9. PubMed ID: 22667460
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of cell invasion and MMP production by a nutrient mixture in malignant liposarcoma cell line SW-872.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2007; 24(4):394-401. PubMed ID: 17917088
[TBL] [Abstract][Full Text] [Related]
47. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effects of a nutrient mixture on human testicular cancer cell line NT 2/DT matrigel invasion and MMP activity.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2007; 24(2):183-8. PubMed ID: 17848742
[TBL] [Abstract][Full Text] [Related]
49. Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion.
Zhao Y; Lyons CE; Xiao A; Templeton DJ; Sang QA; Brew K; Hussaini IM
Biochem Biophys Res Commun; 2008 May; 369(4):1215-20. PubMed ID: 18355442
[TBL] [Abstract][Full Text] [Related]
50. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
[TBL] [Abstract][Full Text] [Related]
51. Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Int J Gynecol Cancer; 2006; 16(3):1241-7. PubMed ID: 16803512
[TBL] [Abstract][Full Text] [Related]
52. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
53. Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis.
Morris-Wiman J; Du Y; Brinkley L
J Craniofac Genet Dev Biol; 1999; 19(4):201-12. PubMed ID: 10731089
[TBL] [Abstract][Full Text] [Related]
54. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
55. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
[TBL] [Abstract][Full Text] [Related]
56. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.
Yodkeeree S; Chaiwangyen W; Garbisa S; Limtrakul P
J Nutr Biochem; 2009 Feb; 20(2):87-95. PubMed ID: 18495463
[TBL] [Abstract][Full Text] [Related]
57. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K
Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950
[TBL] [Abstract][Full Text] [Related]
58. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
59. Intracellular localization of matrix metalloproteinases and their inhibitors in cultured tumor cell lines: flow cytometric analysis.
Koyama S
Oncol Rep; 2006 Mar; 15(3):735-8. PubMed ID: 16465438
[TBL] [Abstract][Full Text] [Related]
60. A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28335466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
